Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke (PAIS)

Guangzhou University of Traditional Chinese Medicine

Status and phase: Completed; Phase 4

Conditions: Acute Ischemic Stroke

Treatments: Drug: aspirin，chinese herbs；

Study type: Interventional

Funder types: Other

Identifiers

NCT00966316

200707004

Details and patient eligibility

About

The purpose of this study is to determine whether the clinical pathway for acute ischemic stroke(with combination of traditional Chinese medicine and western medicine) is able to improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of Clinical Pathway

Full description

Eligibility Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

Those clinically diagnosed with acute ischemic stroke ； 18-85 years old； Over 6 hours and within 14 days from onset 4<=NIHSS <=22; Informed consent signed by patient or his/her family ；

Exclusion Criteria:

Hemorrhagic stroke; Cerebral hernia; Serious heart, liver, lung, kidney functional failure，malignancy; Not cooperative with physician; Psychological disorder; Already taken part in other clinical drug trial within the past 3 months

Enrollment: 314 patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ischemic stroke diagnosed with both criteria of traditional Chinese medicine and western medicine；
• 18-85 years old；
• Over 6 hours and within 14 days from onset
• 4<=NIHSS <=22;
• Informed consent signed by patient or his/her family ；

Exclusion criteria

• Hemorrhagic stroke;
• Cerebral hernia;
• Serious heart, liver, lung, kidney functional failure,malignancy;
• Not cooperative with physician;
• Psychological disorder;
• Already taken part in other clinical drug trial within the past 3 months

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

314 participants in 1 patient group

pathway

Experimental group

Description:

aspirin，Chinese herbs；acupuncture；rehabilitation；health education；

Treatment:

Drug: aspirin，chinese herbs；